Evidence map›Paper›PMID 25488991›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Identification of Aim2 as a sensor for DNA vaccines.

John J Suschak, Shixia Wang, Katherine A Fitzgerald, Shan Lu

Open access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. AIM2 and Psoriasis.Frontiers in immunology · 2023
    Review
  7. Review
  8. Article
  9. Article
  10. The complex role of AIM2 in autoimmune diseases and cancers.Immunity, inflammation and disease · 2021
    Review
  11. Inflammasomes as therapeutic targets in human diseases.Signal transduction and targeted therapy · 2021
    Review
  12. Article
  13. Review
  14. Review
  15. Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants.Frontiers in cellular and infection microbiology · 2021
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

John J SuschakLaboratory of Nucleic Acid Vaccines, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01655; and.
Shixia WangLaboratory of Nucleic Acid Vaccines, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01655; and.
Katherine A FitzgeraldProgram in Innate Immunity, Division of Infectious Diseases, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01655.
Shan LuLaboratory of Nucleic Acid Vaccines, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01655; and shan.lu@umassmed.edu.
University of Massachusetts Chan Medical School · US

Funding

Optimizing the immunogenicity of next generation polyvalent HIV vaccine formulatiU19AI082676 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LU, SHAN · 2009 to 2016
$15.8M
Variation in HIV-1 R5 Envs: Consequences for tropism, neutralization & vaccinesP01AI082274 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LU, SHAN · 2009 to 2013
$9.7M
TRAINING IN IMMUNOLOGY (COMPETITIVE RENEWAL OF AI07439)T32AI007349 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STERN, LAWRENCE J. · 1989 to 2024
$4.5M
DNA sensors and associated signaling pathways in the innate immune responseR01AI093752 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FITZGERALD, KATHERINE A. · 2012 to 2016
$1.7M
Production of neutralizing mAbs from HIV vaccineesR33AI087191 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WANG, SHIXIA · 2012 to 2014
$1.4M
NIAID NIH HHS 5 P01 AI082274NIAID NIH HHS 5 R33 AI087191NIAID NIH HHS 5 U19AI082676NIAID NIH HHS P01 AI082274NIAID NIH HHS R01 AI093752NIAID NIH HHS R33 AI087191NIAID NIH HHS T32 AI007349NIAID NIH HHS U19 AI082676
6 · The paper itself

Abstract

Recent human study data have re-established the value of DNA vaccines, especially in priming high-level Ag-specific Ab responses, but also raised questions about the mechanisms responsible for such effects. Whereas previous reports have shown involvement of downstream signaling molecules in the innate immune system, the current study investigated the role of absent in melanoma 2 (Aim2) as a sensor for DNA vaccines. The Aim2 inflammasome directs maturation of the proinflammatory cytokines IL-1β and IL-18 and an inflammatory form of cell death called pyroptosis. Both the humoral and cellular Ag-specific adaptive responses were significantly reduced in Aim2-deficient mice in an IL-1β/IL-18-independent manner after DNA vaccination. Surprisingly, Aim2-deficient mice also exhibited significantly lower levels of IFN-α/β at the site of injection. These results indicate a previously unreported link between DNA vaccine-induced pyroptotic cell death and vaccine immunogenicity that is instrumental in shaping the Ag-specific immune response to DNA vaccines.

Indexed as

Vaccines, DNAAnimalsDNA-Binding ProteinsHumansImmunity, InnateInflammasomesInterferon-alphaInterferon-betaInterleukin-18Interleukin-1betaMiceMice, KnockoutAim2 protein, mouseDNA-Binding ProteinsIL1B protein, mouseInflammasomesInterferon-alphaInterferon-betaInterleukin-18Interleukin-1betaVaccines, DNA

Identifiers

PMID25488991
PMCPMC4282968
OpenAlexW2144150351

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.